Abstract
Tissue plasminogen activator (t-PA) is being used as thrombolytic therapy for patients with acute myocardial infarction [1], given in combination with anticoagulants such as heparin or warfarin. We compared the effects of the new selective thrombin inhibitors, argatroban and hirudin, with those of heparin, on the thrombolysis mediated by t-PA in an experimental model of thrombosis using the hamster cheek pouch.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marder VJ, Sherry S. (1988) Thrombolytic therapy: current status. N Engl Med 318: 1512–1520
Shanberge JN, Tsuji H, Longe TQ. (1990) Production of thrombi on intact endothelium by use of antiheparins in vivo. J Lab Clin Med 116: 831–839
Ik-Kyung Jang, Herman K. Gold, Robert C. Leinbach, John T. Fallon and Desire Collen. (1990) In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator. Circ Res 67: 1552–1561
Gaffney PJ, Marsh NA, Thomas DP. (1982) The influence of heparin and heparin-like substances on the fibrinolytic system in vivo. Heamostasis 12: 85
Okamoto S, Hijikata A. (1981) Potent inhibition of thrombin by the newly synthesized arginine derivative No.805. The importance of stereostructure of its hydrophobic carboxamide portion. Biochem Biophy Res Commun 101: 440–446
Rosenberg RD. Heparin-antithrombin system. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsch J, Marder VJ, Salzman EW (eds). JP Lippincott, Philadelphia, PA 1987; pp 962–85
Tamao Y, Yamamoto T, Kikumoto R, Hara H, Itoh J, Hirata T, Mineo K, Okamoto S. (1986) Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo. Thromb Heamostas 56: 29–34
Gorog P, Ridler CD, Kovacs IB. (1990) Heparin inhibits spontaneous thrombolysis and thrombolytic effect of both streptokinase and tissue-type plasminogen activator. An in vitro study of the dislodgement of platelet-rich thrombi formed from native blood. J Int Med 227: 125–132
Heras M, Chesebro JH, Penny WJ Bailey KR, Badimon L, Fuster V. (1989) Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 79: 657–665
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Japan
About this paper
Cite this paper
Nakagawa, K. et al. (1993). Effects of Anticoagulants on Thrombolysis Mediated by Tissue Plasminogen Activator in Experimental Thrombosis Model. In: Shen, MC., Teng, CM., Takada, A. (eds) Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68323-0_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-68323-0_13
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70123-1
Online ISBN: 978-4-431-68323-0
eBook Packages: Springer Book Archive